More than 3,000 scientists have now participated in our ongoing tracking survey about the status of their labs and the impact COVID-19 is having on their research. These scientists have shared with us the affect on their lab’s operations, the actions taken by their organizations in response to the pandemic, how they anticipate their lab […]

At BioInformatics Inc. we have the opportunity to explore many different markets on behalf of our clients. In this article we discuss the $50 million market for compact image-based cell analyzers. Broadly, cytometers refer to instruments that can measure various characteristics of cell populations in suspension. Depending on which and how many characteristics or parameters […]

Scientists often claim to be rational in their purchase decisions and consider only price, availability or quality. But for more than 20 years we at BioInformatics LLC have argued that brand awareness, perceptions and loyalty have a very influential role in scientists’ decisions about which instruments and consumables they will purchase for their labs.

Life science tools companies are under increasing pressure to reduce time-to-market and the cost of introducing new products. As product lifecycles continue to decrease, compressing development cycles and accelerating new product introductions are becoming critical. Companies that fail to consistently launch new products will lose ground to more innovative competitors who invest in new and improved […]

Our report Emerging Trends in Marketing to Life Scientists was designed to help marketer’s understand scientists’ receptivity to each of the following techniques used widely in promoting consumer products: Executive branding “Smart instruments” that share data Video and livestreaming Influencer marketing Experiential marketing Sponsored content and native advertising Mobile marketing Website design and digital touchpoints […]

Laboratories around the world are adopting the CRISPR/Cas9 genome editing technique for their research. Whether to engineer better cell lines for drug development or repair mutations that cause genetic diseases, researchers have only begun to tap into the tremendous potential that CRISPR/Cas9 promises. Consequently, the genome editing market, of which CRISPR/Cas9 already accounts for more […]

The study of cells has been instrumental in understanding biological processes. Research on genes and proteins expressed in specific types of cells has typically been performed on samples containing many cells, with analysis reflecting the data averaged across them. But over the last several years, studies have indicated differences in cells of the same type […]

The 2017 Market for NGS Informatics: Probing the Commercial Landscape is designed to help companies navigate the crowded market for products and services that support Next Generation Sequencing (NGS) data analysis and storage. Scientists face many challenges when choosing a solution: it is often difficult to determine the significance of results, the storage space needed […]